CVS
US EQUITY
Health Care
Health Care Services
CIK: 64803
CVS Health (CVS) Quant Factor Diagnostic & Fair Value Model
CVS Health (Ticker: CVS) is listed in the Health Care sector (Health Care Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$93.47
-1.07%
Latest Close (2026-10-23)
Market Cap: $4.33B
P/E Ratio: 10.1
Momentum Strength
3M / 12M
-12.70%
1M: +9.90%
12M: +13.97%
Quality (ROE)
Point-in-Time
+14.91%
Trailing Return on Equity
Technical Trend
RSI 14
69.4
SMA50: $91.61
SMA200: $88.52
Valuation Multiplier
Trailing
10.1
Deep Value (Under 15x P/E)
📊
Valuation & Multi-Factor Diagnostic
Deep Value (Under 15x P/E)
CVS trades at an attractive earnings multiple of 10.1x, significantly lower than the broader S&P 500 average.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 64803 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-05 | $106.10B | $2.98B | $10.59B | $2.31 |
| 10-Q | 2025-12-31 | 2026-08-05 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-05 | $98.92B | $1.02B | $6.45B | $0.80 |
| 10-Q | 2026-03-31 | 2026-05-06 | $100.43B | $2.94B | $4.25B | $2.30 |
| 10-Q | 2025-03-31 | 2026-05-06 | $94.59B | $1.78B | $4.56B | $1.41 |
| 10-K | 2025-12-31 | 2026-02-10 | $402.07B | $1.77B | $10.64B | $1.39 |
| 10-K | 2024-12-31 | 2026-02-10 | $372.81B | $4.61B | $9.11B | $3.66 |
| 10-K | 2023-12-31 | 2026-02-10 | $357.78B | $8.34B | $13.43B | $6.47 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding CVS Health (CVS) valuation multiples, momentum factors, and point-in-time filing conventions.
How should CVS's current valuation multiple be interpreted? ↓
CVS trades at a trailing P/E of 10.1x within the Health Care sector (deep value (under 15x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are CVS's key momentum and technical factor indicators? ↓
As of the latest close, CVS shows a 1-month return of +9.90%, 3-month return of -12.70%, and 12-month return of +13.97%, with a 14-day RSI of 69.4. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for CVS? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can CVS be incorporated into systematic factor models? ↓
CVS can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.